SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Keitaro Iida, Taku Naiki, Noriyasu Kawai, Toshiki Etani, Ryosuke Ando, Yosuke Ikegami, Takehiko Okamura, Hiroki Kubota, Atsushi Okada, Kenjiro Kohri, Takahiro Yasui, Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer, BMC Urology, 2016, 16, 1

    CrossRef

  2. 2
    Samer Bazzi, Helmout Modjtahedi, Satvinder Mudan, Charles Akle, Georges M. Bahr, Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model, Immunobiology, 2015, 220, 12, 1293

    CrossRef

  3. 3
    Tingting Zhang, Xinping Fan, Lili Song, Lu Ren, Enbo Ma, Shengwan Zhang, Liansheng Ren, Yaowu Zheng, Zhang Jianzhen, c-Fos is involved in inhibition of human bladder carcinoma T24 cells by Brazilin, IUBMB Life, 2015, 67, 3
  4. 4
    Gabriella Nesi, Stefania Nobili, Tommaso Cai, Saverio Caini, Raffaella Santi, Chronic inflammation in urothelial bladder cancer, Virchows Archiv, 2015, 467, 6, 623

    CrossRef

  5. 5
    Günter Niegisch, Christina Hulsbergen - van de Kaa, Martine Ploeg, Kees Hendricksen, J. Alfred Witjes, Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?, Bladder Cancer, 2015, 1, 1, 97

    CrossRef

  6. 6
    Fabrizio Dal Moro, Alberto Bovo, Alessandro Crestani, Roberto Vettor, Marina P. Gardiman, Filiberto Zattoni, Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer, Medicine, 2015, 94, 9, e589

    CrossRef

  7. 7
    Ashish M. Kamat, Thomas W. Flaig, H. Barton Grossman, Badrinath Konety, Donald Lamm, Michael A. O'Donnell, Edward Uchio, Jason A. Efstathiou, John A. Taylor, Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer, Nature Reviews Urology, 2015, 12, 4, 225

    CrossRef

  8. 8
    S Viaud, R Daillère, I G Boneca, P Lepage, P Langella, M Chamaillard, M J Pittet, F Ghiringhelli, G Trinchieri, R Goldszmid, L Zitvogel, Gut microbiome and anticancer immune response: really hot Sh*t!, Cell Death and Differentiation, 2015, 22, 2, 199

    CrossRef

  9. 9
    Philip L. Ho, Stephen B. Williams, Ashish M. Kamat, Immune Therapies in Non-Muscle Invasive Bladder Cancer, Current Treatment Options in Oncology, 2015, 16, 2

    CrossRef

  10. 10
    D. R. Killick, A. J. Stell, B. Catchpole, Immunotherapy for canine cancer – Is it time to go back to the future?, Journal of Small Animal Practice, 2015, 56, 4
  11. 11
    Johannes Mischinger, Eva Comperat, Christian Schwentner, Arnulf Stenzl, Georgios Gakis, Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?, Current Urology Reports, 2015, 16, 9

    CrossRef

  12. 12
    Penglong Wang, Xuan Yuan, Yan Wang, Hong Zhao, Xiling Sun, Qiusheng Zheng, Licochalcone�C induces apoptosis via B-cell lymphoma�2 family proteins in T24 cells, Molecular Medicine Reports, 2015,

    CrossRef

  13. 13
    Navid Nezafat, Mohammad Sadraeian, Mohammad Reza Rahbar, Mohammad Javad Khoshnoud, Milad Mohkam, Ahmad Gholami, Mehrzad Banihashemi, Younes Ghasemi, Production of a novel multi-epitope peptide vaccine for cancer immunotherapy in TC-1 tumor-bearing mice, Biologicals, 2015, 43, 1, 11

    CrossRef

  14. 14
    Yonghua Wang, Meng Yang, Qinchao Yu, Lun Yu, Shixiu Shao, Xinsheng Wang, Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies, Expert Review of Anticancer Therapy, 2015, 15, 1, 85

    CrossRef

  15. 15
    Erlin Sun, Xiaodong Fan, Lining Wang, Mingde Lei, Xiaodong Zhou, Chunyu Liu, Bingxin Lu, Xuewu Nian, Yan Sun, Ruifa Han, Recombinant hIFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer, Oncology Reports, 2015,

    CrossRef

  16. 16
    Peter F. Bross, Chaohong Fan, Bindu George, Kevin Shannon, Bharat H. Joshi, Raj K. Puri, Regulation of biologic oncology products in the FDA׳s Center for Biologics Evaluation and Research, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 3, 133

    CrossRef

  17. 17
    K.L. Wycislo, T.M. Fan, The Immunotherapy of Canine Osteosarcoma: A Historical and Systematic Review, Journal of Veterinary Internal Medicine, 2015, 29, 3
  18. 18
    Darragh Duffy, Vincent Rouilly, Valentina Libri, Milena Hasan, Benoit Beitz, Mikael David, Alejandra Urrutia, Aurélie Bisiaux, Samuel T. LaBrie, Annick Dubois, Ivo G. Boneca, Cécile Delval, Stéphanie Thomas, Lars Rogge, Manfred Schmolz, Lluis Quintana-Murci, Matthew L. Albert, Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli, Immunity, 2014, 40, 3, 436

    CrossRef

  19. 19
    Satoe Numakura, Teppei Morikawa, Tetsuo Ushiku, Toyoaki Toyoshima, Masashi Fukayama, Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette–Guérin therapy, Pathology - Research and Practice, 2014, 210, 2, 123

    CrossRef

  20. 20
    Takashi Nakamura, Masafumi Fukiage, Yoshiteru Suzuki, Ikuya Yano, Jun Miyazaki, Hiroyuki Nishiyama, Hideyuki Akaza, Hideyoshi Harashima, Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model, Journal of Controlled Release, 2014, 196, 161

    CrossRef

  21. 21
    Kazuaki Kajimoto, Yusuke Sato, Takashi Nakamura, Yuma Yamada, Hideyoshi Harashima, Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo, Journal of Controlled Release, 2014, 190, 593

    CrossRef

  22. 22
    Takashi Nakamura, Masafumi Fukiage, Megumi Higuchi, Akihiro Nakaya, Ikuya Yano, Jun Miyazaki, Hiroyuki Nishiyama, Hideyuki Akaza, Toshihiro Ito, Hiroyuki Hosokawa, Toshinori Nakayama, Hideyoshi Harashima, Nanoparticulation of BCG-CWS for application to bladder cancer therapy, Journal of Controlled Release, 2014, 176, 44

    CrossRef

  23. 23
    C. Arama, M. Troye-Blomberg, The path of malaria vaccine development: challenges and perspectives, Journal of Internal Medicine, 2014, 275, 5
  24. 24
    Dong Zhang, Peng Sun, Peng Li, Aibing Xue, Xiaokai Zhang, Haiyang Zhang, Xunbo Jin, A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer, Biomaterials, 2013, 34, 38, 10258

    CrossRef

  25. 25
    Christine Gan, Hugh Mostafid, Muhammad Shamim Khan, David J. M. Lewis, BCG immunotherapy for bladder cancer—the effects of substrain differences, Nature Reviews Urology, 2013, 10, 10, 580

    CrossRef

  26. 26
    Adele Mount, Sandra Koernig, Anabel Silva, Debbie Drane, Eugene Maraskovsky, Adriana Baz Morelli, Combination of adjuvants: the future of vaccine design, Expert Review of Vaccines, 2013, 12, 7, 733

    CrossRef

  27. 27
    Meng-Hua Xiong, Yan Bao, Xiao-Jiao Du, Zi-Bin Tan, Qiu Jiang, Hong-Xia Wang, Yan-Hua Zhu, Jun Wang, Differential Anticancer Drug Delivery with a Nanogel Sensitive to Bacteria-Accumulated Tumor Artificial Environment, ACS Nano, 2013, 7, 12, 10636

    CrossRef